We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Key Role Found for Tau Protein in Alzheimer's

By Biotechdaily staff writers
Posted on 27 May 2002
Experiments have revealed evidence that tau protein must be present to enable beta-amyloid to induce the degeneration of brain cells that occurs in Alzheimer's disease. More...
The finding was reported in the April 30, 2002, issue of the Proceedings of the National Academy of Science.

Previous investigations have not been able to determine whether neurofibrillary tau tangles or beta-amyloid plaques are the primary cause of Alzheimer's disease or to find a link between the two. Both are often found in the same brain regions of people with Alzheimer's disease. Now, researchers from Northwestern University Institute for Neuroscience (NUIN, Chicago, IL, USA) have found a definite connection between the two. Their experiments showed that neurons with normal amounts of tau degenerated in the presence of beta-amyloid, while neurons treated to have no tau did not degenerate.

An analysis of the composition of the cytoskeleton of tau-depleted neurons revealed rapid turnover of microtubules, which stabilize the cell's shape and serve as a kind of molecular transport system. This suggests that if neurons can maintain the composition of microtubules with rapid turnover as they age, they may be resistant to neurodegeneration.

"These findings identify the dynamic behavior of the microtubules as a new target for therapeutic intervention,” said Adriana Ferreira, M.D., assistant professor of cell and molecular biology and NUIN researcher. "They also suggest that factors able to induce or restore a more plastic composition of the microtubules might prevent the neuronal degeneration associated with the formation of senile plaques in Alzheimer's disease patients.”




Related Links:
Northwestern Univ.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automated Urinalysis Solution
UN-9000
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.